PUBLIC CONTRACT · 2020
Imunomoduladores - Bevacizumab 25 mg/ml
- Contract value
- €10,657.80
- Signed on
- 27 October 2020
- Procedure
- Direct award, general (Ajuste Direto Regime Geral)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 7532212PUBLISHED SUBJECT
IMUNOMODULADORES - BEVACIZUMAB 25 MG/ML
Parties involved
- Place of performance
- Portugal, Região Autónoma da Madeira, Funchal
- NUTS region
- Not stated
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- Roche · Tax ID 500233810
Values and timeline
- Contract price
- €10,657.80
- Procedure base price
- €11,297.30
- Total effective price
- €10,657.80
- Publication date
- 4 March 2021
- Award date
- 20 October 2020
- Signing date
- 27 October 2020
- Performance period
- 30 days
The contract price is the value agreed in the contract, not the amount paid.
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Direct award, general (Ajuste Direto Regime Geral)
- Award criterion
- Melhor relação qualidade – preço
- CPV code
- 33690000-3 - Medicamentos vários
- Legal basis
- Artigo 24.º, n.º 1, alínea e), subalínea ii) do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos (DL 111-B/2017 ) e DLR no 34/2008/M, de 14.08 (DLR n.º 6/2018/M)
- Framework agreement
- Not stated
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 4890436
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.